Clinical Trial Update: TAC T-cells for the Treatment of HER2-positive Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating TAC T-cells for HER2-positive solid tumors, including HER2-positive gastric cancer and metastatic HER2-positive gastroesophageal junc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Cancer

Drugs mentioned

• TAC-T cells

Snippet

Sponsor: Triumvira Immunologics, Inc. | Conditions: HER2 Positive Gastric Cancer, Metastatic HER2 Positive Gastroesophageal Junction Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2025-06-08